Homœopathic Links 2024; 37(01): 017-023
DOI: 10.1055/s-0043-1770697
Original Article

Evaluation of the Usefulness of Homoeopathic Mother Tincture Sarothamnus Scoparius in Managing Essential Hypertension

Vivek Kumar Shail
1   Department of Practice of Medicine, Rai Bahadur Tunki Sah Government Homoeopathic Medical College & Hospital, Muzaffarpur, Bihar, India
,
2   Regional Research Institute for Homoeopathy, (Under Central Council for Research in Homoeopathy), Agartala, Tripura, India
,
Azizul I. Khadim
3   Regional Research Institute for Homoeopathy, (Under Central Council for Research in Homoeopathy)
,
Kanak Kumar
4   Department of Practice of Medicine, Rai Bahadur Tunki Sah Government Homoeopathic Medical College & Hospital, Muzaffarpur, Bihar, India
,
Abhishek Kumar
4   Department of Practice of Medicine, Rai Bahadur Tunki Sah Government Homoeopathic Medical College & Hospital, Muzaffarpur, Bihar, India
,
Rohit Kumar Priya
4   Department of Practice of Medicine, Rai Bahadur Tunki Sah Government Homoeopathic Medical College & Hospital, Muzaffarpur, Bihar, India
› Author Affiliations
Funding None.

Abstract

Objective The objective of this study was to evaluate the effectiveness of homoeopathic mother tincture Sarothamnus scoparius in the management of essential hypertension.

Materials and Methods An open label, prospective, single arm, clinical trial was conducted on 35 participants recruited from outpatient department/inpatient department of a Govt. Homoeopathic Medical College and Hospital. All participants received Sarothamnus scoparius mother tincture, suffering from essential hypertension. The primary outcome was to evaluate the change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) every month for 3 months and the secondary outcome was to assess the QOL of the patient by using WHOQOL-BREF at baseline and after 3 months. The primary outcome and secondary outcome measures were analysed by repeated measure analysis of variance (ANOVA) and ‘Paired t-test’ respectively.

Result Twenty-nine participants completed the study and six participants dropped out. Intention-to-treat sample (n = 35) was analysed. There was statistically significant reduction in SBP (146.40 ± 7.65 to 128.00 ± 12.34) as well as DBP (88.80 ± 3.26 to 86.07 ± 3.307). Repeated measure ANOVA was performed to compare the changes in SBP as well as DBP at different time interval. In SBP, the result was statistically significant on all occasions (p = 0.000, at 95% confidence interval [CI]). In DBP, the result was also found statistically significant (p = 0.000, at 95% CI). However, the result was not statistically significant when DBP was compared at 1 month with 2nd and 3rd months (p = 1.000, at 95% CI); 2 months with 1 and 3 months (p = 1.000, 0.863 at 95% CI respectively); 2 months with 3 months (p = 0.518, at 95% CI); and 3 months with 1 and 2 months (p = 1.000, 0.863 at 95% CI respectively).

Paired t-test performed to measure the changes in WHOQOL-BREF score showed statistically significant (62.57 ± 10.81 to 96.07 ± 17.47; p = 0.000, at 95% CI).

Conclusion The study findings suggest that Sarothamnus scoparius mother tincture is beneficial in the management of essential hypertension as well as improving QOL. Randomised controlled trials are further warranted.

Note

This study was conducted at the OPD/IPD of R.B.T.S. Govt. Homoeopathic Medical College and Hospital, Muzaffarpur, Bihar, India.


Editor's Note

Though this study lacks in methodological rigor, by not addressing the confounders (LSM and DASH) still we decided to publish this paper because Spartium scoparium is a medicine less often used. This paper can be thought provoking and give an impetus to further research in exploring the role of this drug in Essential Hypertension by carrying out parallel arm randomized trial with one group receiving Placebo with LSM and the other Sarothamnus scoparius and LSM. Since Hypertension is a rampant non-communicable disease, with multiple ramifications, a better study design would definitely help develop a treatment algorithm for hypertension.


Ethical Approval

Ethical clearance was obtained from the Institutional Ethical Committee. Each patient was informed of the ethical issues related to the study through the informed consent form and was duly documented. Patients were instructed to report adverse events, either directly or over the phone. A specific protocol confirming to the Declaration of Helsinki[30] on human experimentation & Good Clinical Practice (GCP) in India[31] was designed for the study.


Trial Registration

The study protocol was approved by the Institutional Ethical Committee (IEC) vide Ref. No.- RBTS/ETHICS-35/2021, dated-23/06/2021 and thereafter registered prospectively in Clinical Trials Registry- India (CTRI) before initiation of the study (CTRI/2021/09/036584).




Publication History

Article published online:
25 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Das SK, Sanyal K, Basu A. Study of urban community survey in India: growing trend of high prevalence of hypertension in a developing country. Int J Med Sci 2005; 2 (02) 70-78
  • 2 World Health Organization. . Global Status Report of NCD 2010. Geneva: World Health Organization, 2011. Accessed May 26, 2023 at: https://apps.who.int/iris/handle/10665/44579
  • 3 Sharma N, Jadhav AB, Patil AV. Study the effectiveness of Lachesismuta 30c in patients with essential hypertension in the age group of 20–75 years. Int J Health Sci Res 2020; 10 (01) 216-220
  • 4 World Health Organization. . Hypertension fact sheets. Geneva: World Health Organization, 2021, Aug 25; Accessed May 26, 2023 at: https://www.who.int/new-room/fact-sheets/detail/hypertension
  • 5 Varanasi R, Kolli R, Rai Y. et al. Effects of individualised homoeopathic intervention in Stage I essential hypertension: A singleblind, randomised, placebo-controlled trial. Indian J Res Homoeopathy 2020; 14: 3-14
  • 6 Joshi V, Dahake A, Suthar A. Adverse effects associated with the use of antihypertensive drugs: an overview. Int J Pharm Tech Res 2010; 2: 10-13
  • 7 Tierney LM, McPhee SJ, Papadakis MA. Current Medical Diagnosis & Treatment. 44th ed. USA: McGraw-Hill Companies Inc; 2005. :1716
  • 8 Mahmoudian A. Homoeopathy effect on high blood pressure. J Res Med Sci 2004; 6: 15-16
  • 9 Mehra P. Usefulness of homoeopathy in essential hypertension: an exploratory interventional trial (Short communication). Int J High Dilution Res 2015; 14: 16-19
  • 10 Saha S, Koley M, Hossain S. et al. Individualized homoeopathy versus placebo in essential hypertension: a double-blind randomized controlled trial. Indian J Res Homoeopathy 2013; 7 (02) 62-71
  • 11 Lakhera BC, Dhawan IM. , Manjushree, Kaushik S, Mishra A, Chugh S. Essential hypertension (Drug related study). Clinical Research Studies Series II. New Delhi: CCRH; 2009
  • 12 Boericke W. Pocket Manual of Homoeopathic Materia-Medica & Repertory. 14th impression. New Delhi: B. Jain (p) Ltd.; 2016
  • 13 Banerjee NK. Blood Pressure: Etiology and Homoeopathic Management, New Revised & enlarged ed. New Delhi: B. Jain Publishers (P) Ltd.; 2009
  • 14 Singh PK, Kumar D, Mathur A. Hypertension & Its Homoeopathic Management. TUJ Homo Medi Sci 2021; 4 (01) 32-41
  • 15 Master FJ. Bedside Clinical Prescribing in Homoeopathy. 3rd Impression. New Delhi: B. Jain Publishers (P) Ltd.; 2018
  • 16 Verma PN, Vaid I. Encyclopaedia of Homoeopathic Pharmacopoeia & Drug Index. Vol II, 4th ed. New Delhi: B. Jain Publishers (P) Ltd.; 2007
  • 17 National Park Service. . Exotic Species: Scotch Broom. NPS 2010; Accessed May 26, 2023 at: https://www.nps.gov/articles/scotch-broom.htm
  • 18 O'Connor JT. American Homoeopathic Pharmacopoeia. 6th ed. Philadelphia: Boericke & Tafel; 1899
  • 19 Richard CL, Jurgens TM. Effects of natural health products on blood pressure. Ann Pharmacother 2005; 39 (04) 712-720
  • 20 Caramelo D, Barroca C, Guine R, Gallardo E, Anjos O, Gominho J. Potential applications of the Cytisus shrub species: Cytisusmultiflorus, Cytisusscoparius, and Cytisusstriatus. Processes (Basel) 2022; 10: 1-17
  • 21 Ohta Y, Tsuchihashi T, Kiyohara K. Relationship between blood pressure control status and lifestyle in hypertensive outpatients. Intern Med 2011; 50 (19) 2107-2112
  • 22 NIH. . Dash eating plan. NIH 2021; Accessed May 26, 2023 at: https://www.nhlbi.nih.gov/education/dash-eating-plan
  • 23 World Health Organization. . Abbreviated World Health Organization Quality of life questionnaire (WHOQOL-BREF), Geneva. World Health Organization. Accessed May 26, 2023 at: https://www.who.int/tools/whoqol/whoqol-bref
  • 24 IBM Corp. SPSS Software, version 22. New York: IBM SPSS Statistics; 2020.
  • 25 Landi F, Calvani R, Picca A. et al. Body mass index is strongly associated with hypertension: results from the longevity check-up 7+ study. Nutrients 2018; 10 (12) 1-12
  • 26 Schroyens F. Synthesis-Repertorium Homeopathicum Synthethicum, Radar Opus Pro. New Delhi: B. Jain Exclusive; 2016
  • 27 Jack RAF. Severe hypertension treated with Spartium scoparium and its constitutional homoeopathic remedy. Br Homeopath J 1979; 68 (01) 39-50
  • 28 Surekha T, Preethi B. To endeavor the effect of Spartium scoparium in essential hypertension. Int J Homoeopath Sci 2023; 7 (01) 68-71
  • 29 Acharya T, Acharya A, Mehrotra S. Effect of lesser known homoeopathic medicines on hypertension: a pilot study. World J Pharm Res 2018; 7 (16) 879-888
  • 30 WMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects. . Accessed May 26, 2023 at: https://www.wma.net/wp-content/uploads/2016/11/DoH-Oct2008.pdf
  • 31 Good Clinical Practices for Clinical Research in India. . New Delhi: CDSCO; 2001. Central Drugs Standard Control Organization, Directorate General of Health Services, India. Accessed May 26, 2023 at: https://rgcb.res.in/documents/Good-Clinical-Practice-Guideline.pdf